Page last updated: 2024-11-04

sulfasalazine and Leukemoid Reaction

sulfasalazine has been researched along with Leukemoid Reaction in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Leukemoid Reaction: A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, S1
Tanimoto, K1
Okamura, S1

Other Studies

1 other study available for sulfasalazine and Leukemoid Reaction

ArticleYear
[Transient leukemoid reaction of plasma cells in a patient with rheumatoid arthritis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:8

    Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Leukemoid Reaction; Methotrexate; Plasma Cells; Sulfasa

2007